T Cells With Known Specificity Used to Determine the Treg Response in Lung Injury

During development, many conventional self-antigen-specific T cells mature in the peripheral immune system. In their steady state, these T cells are heavily regulated by multiple overlapping mechanisms of tolerance. However, inflammatory conditions such as tissue injury may allow the cells to break tolerance and trigger autoimmunity.

Subscribe to the latest updates from Rheumatology, Allergy and Immunology Advances in Motion

Error: Please enter a valid email address.

Email Address Submit

James J. Moon, PhD, a principal investigator in the Center for Immunology and Inflammatory Diseases at Massachusetts General Hospital, Daniel S. Shin, MD, PhD, a postdoctoral fellow in the Moon Lab, and colleagues recently characterized how the activation of self-antigen-specific T cells occurs during the early stages of inflammatory tissue injury. In Cell Reports, they present crucial insights into how steady-state peripheral tolerance may fail under inflammatory conditions.

Methods

Studying the physiologic response of self-antigen-specific T cells upon recognition of their cognate antigen during inflammation is technically challenging because there are extremely low frequencies of T cells specific for any given antigen.

To overcome this barrier, the Moon Lab has developed the use of peptide:major histocompatibility complex (MHC) tetramer-based cell enrichment techniques with model antigen-bearing mice to directly identify and analyze endogenous self-antigen-specific T-cell populations that are regulated in the steady state in a tissue-specific manner.

In this study, they used that system to directly address how immune-mediated lung injury in the mice leads to activation of endogenous self-antigen-specific CD4+ T cells.

Expansion of Self-Antigen-Specific T_regs

In response to self-antigen presentation during acute lung injury from the infusion of autoreactive CD4+ T cells, the team observed an expansion of host CD4+ T cells almost exclusively within the Foxp3-expressing compartment. This resulted in a strong skewing of the self-antigen-specific population toward a CD4+ regulatory T (T_reg) cell phenotype that suppressed inflammation.

Preferential activation of self-antigen-specific CD4+ T_reg cells was also seen in:

• A pancreatic self-antigen model
• Lung injury from CD8+ T cell–mediated autoimmunity
• An antigen-free model of acute lung injury produced by Escherichia coli–derived lipopolysaccharide (LPS)

The expansion of self-antigen-specific T_regs was dependent on T-cell receptor and interleukin-2 signaling.

Generalized Tissue Injury Model

After intranasal LPS administration, Foxp3+ T_reg cells were not detected within the lungs of mice that harbored a peripheral T-cell repertoire with limited self-antigen specificity, and those mice experienced more weight loss than mice with normal repertoires.

Mice treated with an interleukin-2–blocking antibody or experienced T_reg ablation similarly fared worse after intranasal LPS administration.

These results imply that expansion and localization of T_reg cells at the site of tissue damage may arise from T-cell clones that harbor self-reactivity and that such T_reg cells are important in regulating the ongoing inflammation.

Commentary

The self-antigen-specific CD4+ T cells that polarize toward a regulatory fate seem to represent a larger repertoire of self-reactive T_regs that mobilize in response to tissue injury and help regulate further tissue damage. Further research into the mechanisms underlying the preferential expansion of these T_regs and characterization of their effector functions should provide insight into potential therapeutic strategies for modulating self-reactive T_regs in human disease.

view original journal article Subscription may be required

Explore research in the Center for Immunology & Inflammatory Diseases

Learn about the Division of Rheumatology, Allergy & Immunology